So to start off, could you provide an overview of EPP and XLP? What are the common symptoms, current treatment options, and what that disease burden looks like for patients?

Yeah, thanks for this question.

And here at Leo, we always start with patients and their caregivers.

As you will learn, EPP and XLP, the first symptoms often start in childhood.

So people living with EPP and XLP, they face an extreme burden.

There's limited treatment options.

It's devastating, it's a lifelong disease, and it can severely impact patients' ability to live every day, their everyday lives free from sunlight-induced pain.

Can you talk about Leo Pharma's commitment to rare dermatology and rare skin diseases?